WeChat Mini Program

Old Version Features

Log in

Academic Profile User Profile

My Following Paper Collections Browse History

ANCHOR: Melflufen Plus Dexamethasone and Daratumumab or Bortezomib in Relapsed/refractory Multiple Myeloma: Final Results of a Phase I/IIa Study.

Enrique M. Ocio,Yvonne A. Efebera,Roman Hajek,Jan Straub,Vladimir Maisnar,Jean-Richard Eveillard,Lionel Karlin,Maria -Victoria Mateos,Albert Oriol,Vincent Ribrag,Paul G. Richardson,Stefan Norin,Jakob Obermueller,Nicolaas A. Bakker,Ludek Pour

Haematologica（2024）

Cited 2|Views70

Key words

International Myeloma Working Group

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined